{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:45:36Z","timestamp":1774878336245,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32100749"],"award-info":[{"award-number":["32100749"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82341041"],"award-info":[{"award-number":["82341041"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Science and Technology Innovation Action Plan","award":["22Y11901000"],"award-info":[{"award-number":["22Y11901000"]}]},{"name":"Shenzhen Medical Research Fund","award":["B2302044"],"award-info":[{"award-number":["B2302044"]}]},{"name":"Shenzhen Science and Technology Program","award":["RCJC20210706092009004"],"award-info":[{"award-number":["RCJC20210706092009004"]}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2021YFC2302602"],"award-info":[{"award-number":["2021YFC2302602"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-026-01403-1","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T14:47:41Z","timestamp":1771598861000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A modular three in one mucosal vaccine against three antigenic clusters of ACE2 using sarbecoviruses"],"prefix":"10.1038","volume":"11","author":[{"given":"Lin","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haofeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shasha","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengxin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunqi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Qin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingguo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"1403_CR1","doi-asserted-by":"crossref","unstructured":"Counoupas, C. et al. An adjuvanted chimeric spike antigen boosts lung-resident memory T-cells and induces pan-sarbecovirus protective immunity. Npj Vaccines 10, 89 (2025).","DOI":"10.1038\/s41541-025-01144-7"},{"key":"1403_CR2","doi-asserted-by":"crossref","unstructured":"Nie, J. H. et al. Functional comparison of SARS-CoV-2 with closely related pangolin and bat coronaviruses. Cell Discov. 7, 21 (2021).","DOI":"10.1038\/s41421-021-00256-3"},{"key":"1403_CR3","doi-asserted-by":"crossref","unstructured":"Marani, M., Katul, G. G., Pan, W. K. & Parolari, A. J. Intensity and frequency of extreme novel epidemics. Proc. Natl. Acad. Sci. USA 118, e2105482118 (2021).","DOI":"10.1073\/pnas.2105482118"},{"key":"1403_CR4","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.chom.2022.11.016","volume":"31","author":"DM Morens","year":"2023","unstructured":"Morens, D. M., Taubenberger, J. K. & Fauci, A. S. Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses. Cell Host Microbe 31, 146\u2013157 (2023).","journal-title":"Cell Host Microbe"},{"key":"1403_CR5","doi-asserted-by":"crossref","unstructured":"Ahn, J. H. et al. Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19. J. Clin. Investig. 131, e148517 (2021).","DOI":"10.1172\/JCI148517"},{"key":"1403_CR6","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41586-022-04399-5","volume":"602","author":"JM Carre\u00f1o","year":"2022","unstructured":"Carre\u00f1o, J. M. et al. Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron. Nature 602, 682\u201368 (2022).","journal-title":"Nature"},{"key":"1403_CR7","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.chom.2023.05.017","volume":"31","author":"CW Tan","year":"2023","unstructured":"Tan, C. W., Valkenburg, S. A., Poon, L. L. M. & Wang, L. F. Broad-spectrum pan-genus and pan-family virus vaccines. Cell Host Microbe 31, 902\u2013916 (2023).","journal-title":"Cell Host Microbe"},{"key":"1403_CR8","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/s41423-022-00929-3","volume":"19","author":"JY Yang","year":"2022","unstructured":"Yang, J. Y. et al. A triple-RBD-based mucosal vaccine provides broad protection against SARS-CoV-2 variants of concern. Cell Mol. Immunol. 19, 1279\u20131289 (2022).","journal-title":"Cell Mol. Immunol."},{"key":"1403_CR9","doi-asserted-by":"crossref","unstructured":"Li, X. et al. Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants including JN.1. Signal Transduct. Target 9, 114 (2024).","DOI":"10.1038\/s41392-024-01822-3"},{"key":"1403_CR10","doi-asserted-by":"crossref","unstructured":"Martinez, D. R. et al. A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice. Sci. Transl. Med. 14, eabj7125 (2022).","DOI":"10.1126\/scitranslmed.abj7125"},{"key":"1403_CR11","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.1038\/s41586-022-05048-7","volume":"607","author":"S Temmam","year":"2022","unstructured":"Temmam, S. et al. Bat coronaviruses related to SARS-CoV-2 and infectious for human cells (vol 604, pg 330, 2022). Nature 607, E19 (2022).","journal-title":"Nature"},{"key":"1403_CR12","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2025.01.042","volume":"188","author":"J Chen","year":"2025","unstructured":"Chen, J. et al. Bat-infecting merbecovirus HKU5-CoV lineage 2 can use human ACE2 as a cell entry receptor. Cell 188, 1729\u20131742.e16 (2025).","journal-title":"Cell"},{"key":"1403_CR13","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nature12711","volume":"503","author":"XY Ge","year":"2013","unstructured":"Ge, X. Y. et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature 503, 535\u2013553 (2013).","journal-title":"Nature"},{"key":"1403_CR14","doi-asserted-by":"publisher","first-page":"114235","DOI":"10.1016\/j.celrep.2024.114235","volume":"43","author":"CY Liu","year":"2024","unstructured":"Liu, C. Y. et al. Mosaic RBD nanoparticle elicits immunodominant antibody responses across sarbecoviruses. Cell Rep. 43, 114235 (2024).","journal-title":"Cell Rep."},{"key":"1403_CR15","doi-asserted-by":"publisher","first-page":"e0016922","DOI":"10.1128\/jvi.00169-22","volume":"96","author":"MQ Liu","year":"2022","unstructured":"Liu, M. Q. et al. Inactivated SARS-CoV-2 vaccine shows cross-protection against bat SARS-related coronaviruses in human ACE2 transgenic mice. J. Virol. 96, e0016922 (2022).","journal-title":"J. Virol."},{"key":"1403_CR16","doi-asserted-by":"crossref","unstructured":"He, B. et al. Rapid isolation and immune profiling of SARS-CoV-2 specific memory B cell in convalescent COVID-19 patients via LIBRA-seq. Signal Transduct. Target 6, 195 (2021).","DOI":"10.1038\/s41392-021-00610-7"},{"key":"1403_CR17","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1126\/science.abc2241","volume":"368","author":"Y Wu","year":"2020","unstructured":"Wu, Y. et al. A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2. Science 368, 1274\u20131278 (2020).","journal-title":"Science"},{"key":"1403_CR18","doi-asserted-by":"publisher","first-page":"108274","DOI":"10.1016\/j.celrep.2020.108274","volume":"33","author":"NC Wu","year":"2020","unstructured":"Wu, N. C. et al. An alternative binding mode of IGHV3-53 antibodies to the SARS-CoV-2 receptor binding domain. Cell Rep. 33, 108274 (2020).","journal-title":"Cell Rep."},{"key":"1403_CR19","doi-asserted-by":"publisher","first-page":"e0079023","DOI":"10.1128\/jvi.00790-23","volume":"97","author":"HF Lin","year":"2023","unstructured":"Lin, H. F. et al. Characterization of a mouse-adapted strain of bat severe acute respiratory syndrome-related coronavirus. J. Virol. 97, e0079023 (2023).","journal-title":"J. Virol."},{"key":"1403_CR20","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.4161\/hv.23809","volume":"9","author":"JY Yang","year":"2013","unstructured":"Yang, J. Y. et al. Antigen replacement of domains D2 and D3 in flagellin promotes mucosal IgA production and attenuates flagellin-induced inflammatory response after intranasal immunization. Hum. Vaccines Immunother. 9, 1084\u20131092 (2013).","journal-title":"Hum. Vaccines Immunother."},{"key":"1403_CR21","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/cmi.2017.78","volume":"14","author":"MH Zhong","year":"2017","unstructured":"Zhong, M. H., Yan, H. M. & Li, Y. M. Flagellin: a unique microbe-associated molecular pattern and a multi-faceted immunomodulator. Cell Mol. Immunol. 14, 862\u2013864 (2017).","journal-title":"Cell Mol. Immunol."},{"key":"1403_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1189\/jlb.3HI0816-368RR","volume":"102","author":"Y Cao","year":"2017","unstructured":"Cao, Y. et al. Frontline science: nasal epithelial GM-CSF contributes to TLR5-mediated modulation of airway dendritic cells and subsequent IgA response. J. Leukoc. Biol. 102, 575\u2013587 (2017).","journal-title":"J. Leukoc. Biol."},{"key":"1403_CR23","doi-asserted-by":"publisher","first-page":"109401","DOI":"10.1016\/j.celrep.2021.109401","volume":"36","author":"BL Zhao","year":"2021","unstructured":"Zhao, B. L. et al. A safe and effective mucosal RSV vaccine in mice consisting of RSV phosphoprotein and flagellin variant. Cell Rep. 36, 109401 (2021).","journal-title":"Cell Rep."},{"key":"1403_CR24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cell.2020.05.027","volume":"182","author":"RD Jiang","year":"2020","unstructured":"Jiang, R. D. et al. Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2. Cell 182, 50\u201355 (2020).","journal-title":"Cell"},{"key":"1403_CR25","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41586-020-2599-8","volume":"586","author":"JY Yang","year":"2020","unstructured":"Yang, J. Y. et al. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature 586, 572\u2013577 (2020).","journal-title":"Nature"},{"key":"1403_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41577-020-00480-0","volume":"21","author":"LP Dai","year":"2021","unstructured":"Dai, L. P. & Gao, G. F. Viral targets for vaccines against COVID-19. Nat. Rev. Immunol. 21, 73\u201382 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"1403_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41423-023-01116-8","volume":"21","author":"S Cankat","year":"2024","unstructured":"Cankat, S., Demael, M. U. & Swadling, L. In search of a pan-coronavirus vaccine: next-generation vaccine design and immune mechanisms. Cell Mol. Immunol. 21, 103\u2013118 (2024).","journal-title":"Cell Mol. Immunol."},{"key":"1403_CR28","doi-asserted-by":"publisher","first-page":"e2501637122","DOI":"10.1073\/pnas.2501637122","volume":"122","author":"CC Fan","year":"2025","unstructured":"Fan, C. C. et al. Cross-reactive sarbecovirus antibodies induced by mosaic RBD nanoparticles. Proc. Natl. Acad. Sci. USA 122, e2501637122 (2025).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1403_CR29","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.1016\/j.cell.2024.07.052","volume":"187","author":"AA Cohen","year":"2024","unstructured":"Cohen, A. A. et al. Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals. Cell 187, 5554\u20135571.e19 (2024).","journal-title":"Cell"},{"key":"1403_CR30","doi-asserted-by":"publisher","first-page":"100974","DOI":"10.1016\/j.lanmic.2024.100974","volume":"6","author":"LY Li","year":"2025","unstructured":"Li, L. Y. & Zhou, H. Development of an all-in-one pan-sarbecovirus ferritin nanoparticle vaccine in humans. Lancet Microbe 6, 100974 (2025).","journal-title":"Lancet Microbe"},{"key":"1403_CR31","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41586-023-06809-8","volume":"624","author":"T Ye","year":"2023","unstructured":"Ye, T. et al. Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization. Nature 624, 630\u2013663 (2023).","journal-title":"Nature"},{"key":"1403_CR32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41392-023-01421-8","volume":"8","author":"JY Yang","year":"2023","unstructured":"Yang, J. Y. et al. The protective nasal boosting of a triple-RBD subunit vaccine against SARS-CoV-2 following inactivated virus vaccination. Signal Transduct. Target 8, 151 (2023).","journal-title":"Signal Transduct. Target"},{"key":"1403_CR33","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1016\/j.chom.2024.10.016","volume":"32","author":"JB Case","year":"2024","unstructured":"Case, J. B. et al. A trivalent mucosal vaccine encoding phylogenetically inferred ancestral RBD sequences confers pan-Sarbecovirus protection in mice. Cell Host Microbe 32, 2131\u20132147.e8 (2024).","journal-title":"Cell Host Microbe"},{"key":"1403_CR34","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41590-024-02072-9","volume":"26","author":"AR Zhu","year":"2025","unstructured":"Zhu, A. R. et al. Robust mucosal SARS-CoV-2-specific T cells effectively combat COVID-19 and establish polyfunctional resident memory in patient lungs. Nat. Immunol. 26, 459\u2013472 (2025).","journal-title":"Nat. Immunol."},{"key":"1403_CR35","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.immuni.2020.11.016","volume":"53","author":"P Bacher","year":"2020","unstructured":"Bacher, P. et al. Low-avidity CD4T cell responses to SARS-CoV-2 in unexposed individuals and humans with severe COVID-19. Immunity 53, 1258\u20131271 (2020).","journal-title":"Immunity"},{"key":"1403_CR36","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.immuni.2016.05.006","volume":"44","author":"JC Zhao","year":"2016","unstructured":"Zhao, J. C. et al. Airway memory CD4T cells mediate protective immunity against emerging respiratory coronaviruses. Immunity 44, 1379\u20131391 (2016).","journal-title":"Immunity"},{"key":"1403_CR37","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/mi.2017.14","volume":"11","author":"DG Eliasson","year":"2018","unstructured":"Eliasson, D. G. et al. M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection. Mucosal Immunol. 11, 273\u2013289 (2018).","journal-title":"Mucosal Immunol."},{"key":"1403_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19741-6","volume":"11","author":"H Peckham","year":"2020","unstructured":"Peckham, H. et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat. Commun. 11, 6317 (2020).","journal-title":"Nat. Commun."},{"key":"1403_CR39","doi-asserted-by":"publisher","first-page":"e24296","DOI":"10.1371\/journal.pone.0024296","volume":"6","author":"Y Zhang","year":"2011","unstructured":"Zhang, Y. et al. Unpolarized release of vaccinia virus and HIV antigen by colchicine treatment enhances intranasal HIV antigen expression and mucosal humoral responses. PLoS ONE 6, e24296 (2011).","journal-title":"PLoS ONE"}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01403-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01403-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01403-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T12:48:19Z","timestamp":1774874899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01403-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1403"],"URL":"https:\/\/doi.org\/10.1038\/s41541-026-01403-1","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"76"}}